Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%

TXSeries for Multiplatforms — Vulnerabilities & Security Advisories 18

All 18 CVE vulnerabilities found in TXSeries for Multiplatforms, with AI-generated Chinese analysis, references, and POCs.

Vendor: IBM

CVE IDTitleCVSSSeverityPublished
CVE-2024-56476 IBM TXSeries for Multiplatforms information disclosure CWE-204 5.3 Medium2025-04-02
CVE-2024-56475 IBM TXSeries for Multiplatforms cross-site scripting CWE-79 5.4 Medium2025-04-02
CVE-2024-56474 IBM TXSeries for Multiplatforms cross-site request forgery CWE-352 4.3 Medium2025-04-02
CVE-2025-0154 IBM TXSeries for Multiplatforms information disclosure CWE-644 5.3 Medium2025-04-02
CVE-2024-41742 IBM TXSeries for Multiplatforms denial of service CWE-770 7.5 High2025-01-19
CVE-2024-41743 IBM TXSeries for Multiplatforms denial of service CWE-770 7.5 High2025-01-19
CVE-2024-41741 IBM TXSeries for Multiplatforms information disclosure CWE-208 5.3 Medium2024-11-01
CVE-2024-41738 IBM TXSeries for Multiplatforms information disclosure CWE-598 5.9 Medium2024-11-01
CVE-2024-22345 IBM TXSeries for Multiplatforms information disclosure CWE-522 6.2 Medium2024-05-10
CVE-2024-22344 IBM TXSeries for Multiplatforms information disclosure 6.1 Medium2024-05-10
CVE-2024-22343 IBM TXSeries for Multiplatforms information disclosure CWE-525 4.0 Medium2024-05-10
CVE-2023-42031 IBM CICS TX denial of service CWE-400 4.9 Medium2023-10-24
CVE-2023-33850 IBM GSKit-Crypto information disclosure CWE-203 7.5 High2023-08-22
CVE-2023-38741 IBM TXSeries for Multiplatforms denial of service CWE-400 7.5 High2023-08-14
CVE-2023-33846 IBM CICS TX cross-site scripting CWE-79 5.4 Medium2023-06-08
CVE-2023-33847 IBM CICS TX information disclosure 3.7 Low2023-06-08
CVE-2023-33849 IBM CICS TX information disclosure CWE-311 3.7 Low2023-06-07
CVE-2023-33848 IBM CICS TX information disclosure CWE-200 4.9 Medium2023-06-07

All 18 known CVE vulnerabilities affecting TXSeries for Multiplatforms with full Chinese analysis, references, and POCs where available.